Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment

Open access

Abstract

The Microbiota Makes for Good Therapy: The gut microbiota has been implicated in the development of some cancers, such as colorectal cancer, but—given the important role our intestinal habitants play in metabolism—they may also modulate the efficacy of certain cancer therapeutics. Iida et al. (p. 967 ) evaluated the impact of the microbiota on the efficacy of an immunotherapy [CpG (the cytosine, guanosine, phosphodiester link) oligonucleotides] and oxaliplatin, a platinum compound used as a chemotherapeutic. Both therapies were reduced in efficacy in tumor-bearing mice that lacked microbiota, with the microbiota important for activating the innate immune response against the tumors. Viaud et al. (p. 971 ) found a similar effect of the microbiota on tumor-bearing mice treated with cyclophosphamide, but in this case it appeared that the microbiota promoted an adaptive immune response against the tumors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.1240527

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

25 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 2,251

Metadata

Authors
Iida, N., Dzutsev, A., Stewart, C. A., Smith, L., Bouladoux, N., Weingarten, R. A., Molina, D. A., Salcedo, R., Back, T., Cramer, S., Dai, R.-M., Kiu, H., Cardone, M., Naik, S., Patri, A. K., Wang, E., Marincola, F. M., Frank, K. M., Belkaid, Y., Trinchieri, G., & Goldszmid, R. S.
Affiliations
  • National Cancer Institute (US)
  • National Institute of Allergy and Infectious Diseases (US)
  • National Institutes of Health (US)
  • Technical Resources International (United States) (US)
  • Leidos Biomedical Research Inc. (United States) (US)
Corresponding author
  • Iida, Noriho
  • Dzutsev, Amiran
  • Stewart, C. Andrew
  • Trinchieri, Giorgio
  • Goldszmid, Romina S.
Venue
Science
Published
2013-11-22
Volume
342
Issue
6161
Pages
967-970
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W2124632458
Cited by
2,251
References
36
Citations by year
2026: 100 · 2025: 184 · 2024: 214 · 2023: 251 · 2022: 295 · 2021: 248 · 2020: 247 · 2019: 173 · 2018: 151 · 2017: 124 · 2016: 96 · 2015: 91 · 2014: 71 · 2013: 4
FWCI
38.89
Type
journal article
Language
en
Open access
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (ZIABC010793, ZIABC011153)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords
gut microbiota, commensal bacteria, tumor microenvironment, cancer immunotherapy, platinum-based chemotherapy, myeloid-derived cells, inflammation, germ-free mice, antibiotic therapy, reactive oxygen species, cytokine production, tumor necrosis, tumor-infiltrating immune cells
MeSH terms
Oxaliplatin, Animals, Anti-Bacterial Agents, Antineoplastic Agents, Bacteria, Gene Expression Regulation, Germ-Free Life, Immunotherapy, Inflammation, Intestines, Melanoma, Experimental, Mice, Inbred C57BL, Neoplasm Transplantation, Neoplasms, Oligodeoxyribonucleotides, Organoplatinum Compounds, Phagocytosis, Symbiosis, Tumor Necrosis Factor-alpha, Down-Regulation, Reactive Oxygen Species, Antigen Presentation, Bacterial Physiological Phenomena, Mice, Tumor Microenvironment, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.